BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Kraig Biocraft Laboratories Expands Team With Appointment of New Molecular Biologist

  Over the next 60 days the Company plans to hire additional research staff to support this role as the Company rapidly ramps up development of new and stronger transgenics and polymers.

  December 4, 2017

   · 

  2 min read
• Drug Development

  Saniona Selects Preclinical Candidate in GABAA a2/a3 Program for Neuropathic Pain and Chronic Itching

  The nomination is consistent with Saniona’s strategy to progress innovative products from its internal research pipeline towards clinical development prior to partnering.

  December 4, 2017

   · 

  6 min read
• Drug Development

  Biophytis Has FAMHP Approval to Conduct SARA-INT Phase IIb Interventional Study of Sarconeos in Sarcopenia in Belgium

  The FAMHP approval will enable BIOPHYTIS to initiate the SARA-INT phase 2b interventional study in 3 clinical centers in Belgium.

  December 4, 2017

   · 

  6 min read
• Pharm Country

  Hoth Therapeutics Announces Issuance of First U.S. Patent on its BioLexa Platform

  The new patent is part of the technology portfolio Hoth is developing under an exclusive license from the UC.

  December 4, 2017

   · 

  2 min read
• Biotech Bay

  Ava Launches Clinical Trial Monitoring Use of Bracelet Among Women with Highly Irregular Cycles, Including Those With PCOS

  The new study seeks to examine possible future extension of the services Ava already offers for women with regular cycles - detection of the fertile window - to women with irregular cycles, including women with PCOS.

  December 4, 2017

   · 

  2 min read
• Drug Development

  Zynerba Pharmaceuticals Announces New ZYN002 Data From STAR 1 and STAR 2 Studies in Patients With Focal Seizures at the 2017 Annual Meeting of the American Epilepsy Society (AES)

  The key findings include that clinically meaningful responses to ZYN002, as measured by reductions in focal seizures from the baseline period of STAR 1, are correlated with continued treatment with ZYN002.

  December 4, 2017

   · 

  9 min read
• Policy

  Propanc Biopharma Advances Towards GMP Manufacture of PRP for Human Trials

  PRP is a solution for once-daily intravenous administration of a combination of two pancreatic proenzymes trypsinogen and chymotrypsinogen.

  December 4, 2017

   · 

  6 min read
• Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10M in Series B Funding

  SBI Japan-Israel Innovation Fund and Milestone Venture also participated in the round.

  December 4, 2017

   · 

  3 min read
• Drug Development

  Spruce Biosciences Receives FDA Orphan Drug Designation for SPR001 for the Treatment of Congenital Adrenal Hyperplasia

  Spruce Biosciences today announced that the FDA has granted orphan drug designation for SPR001 for the treatment of congenital adrenal hyperplasia.

  December 4, 2017

   · 

  2 min read
• Business

  BioStem Technologies Announces the Addition of University of Miami Professor Brant D. Watson, Ph.D., to the Company’s Scientific Advisory Board

  Dr. Watson’s research was funded by the National Institute of Neurological Diseases and Stroke for 22 years.

  December 4, 2017

   · 

  3 min read